Clinical trial
Quality of Life Study in Patients With Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent
NCT02836379 is registered in ClinicalTrials.gov with Angelini Farmacéutica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quality of Life Study in Patients With Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent
- Lead sponsor
- Angelini Farmacéutica
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 8, 2016
- Completion date
- February 28, 2018
- Enrollment
- 79 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.